- Stealthy startup Treeline plans a reverse mergerLed by former Loxo Oncology CEO Josh Bilenker, the startup now has a trio of cancer drugs in early-stage testing and more following closely behind.BioPharma Dive · 1mo ago↗ source
- Trump administration warns more than 500 hospitals to provide more price information or face finesThe Trump administration has warned more than 500 hospitals that they are failing to provide the public with basic pricing information.STAT · 1mo ago↗ source
- Gilead and Merck’s latest trial success and flopAstraZeneca's GLP-1 pill, GSK's $10.6B cancer startup acquisition, and more biotech news from The ReadoutSTAT · 1mo ago↗ source